OPTOFLUIDICS, INC.

Company Information
Address 3711 Market Street
Philadelphia, PA, 19104-5504

http://opfluid.com

Information

DUNS: 963268151

# of Employees: 7


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Protein Qspec: An Improved Method for Rapid Characterization of Protein Aggregates in Biologic Drugs for Increased Quality and Safety

    Amount: $99,993.18

    Optofluidics will develop Protein Qspec, a new particle analysis QC instrument designed to characterize protein aggregates in biologic drugs. The primary concern for this class of therapeutics is that ...

    SBIRPhase I2016National Institute of Standards and Technology Department of Commerce
  2. FlowID: An Advanced Particle Imaging and Identification System to Improve the Health and Safety of Protein Therapeutics

    Amount: $749,999.00

    Abstract Optofluidics Inc proposes to develop FlowID a particle analysis quality control method designed to identify unwanted particles in therapeutic proteins that are injected directly into patien ...

    SBIRPhase II2016Department of Health and Human Services
  3. Excelsior: A High Throughput Particle Spectroscopic Characterization System for Biologic QA/QC

    Amount: $150,000.00

    DESCRIPTION provided by applicant Optofluidics Inc proposes to develop the andquot Excelsiorandquot a high throughput nanoparticle enumeration and speciation ID instrument for QA QC in protei ...

    SBIRPhase I2015Department of Health and Human Services
  4. BioPrism- An Optical Chromatograph

    Amount: $985,894.00

    DESCRIPTION provided by applicant Optofluidics Inc proposes to develop a near field optical chromatograph the BioPrism and apply it to the characterization of particle coating stability in nanom ...

    SBIRPhase II2014Department of Health and Human Services National Institutes of Health
  5. QuitAdvisorDDS: A Point-of-Care Tobacco Cessation Tool for Dental Settings

    Amount: $99,841.00

    DESCRIPTION: Optofluidics Inc. proposes to develop a novel protein-binding assay platform called the BioPrism. The Bioprism is a multiplexable, label-free, bead-based binding assay. The system will b ...

    SBIRPhase I2013Department of Health and Human Services
  6. SBIR Phase II: Single Molecule NanoTweezers

    Amount: $499,591.00

    This Small Business Innovation Research Phase II project aims to develop a commercial optically-resonant nanotweezer chip and corresponding instrumentation. The nanotweezer technology, originally deve ...

    SBIRPhase II2012National Science Foundation
  7. Point of Injury Sampling Technology for Battlefield Molecular Diagnostics

    Amount: $1,375,238.00

    In this project Optofluidics, Inc. proposes to develop the Molecular Medic a point-of-care device for sample collection, processing, and quantification of blood-borne biomarkers. The technology is b ...

    SBIRPhase II2012Defense Advanced Research Projects Agency Department of Defense
  8. SBIR Phase I: Single Molecule NanoTweezers

    Amount: $149,370.00

    This Small Business Innovation Research Phase I project aims to develop a commercial optically resonant nanotweezer chip. The nanotweezer technology, originally developed at Cornell University, uses p ...

    SBIRPhase I2011National Science Foundation
  9. "Point of Injury"Sampling Technology for Battlefield Molecular Diagnostics

    Amount: $99,811.00

    In this project Optofluidics, Inc. proposes to develop a"CLIA waivable"sample collection method for the concentration and quantification of blood-borne biomarkers associated with late phase ...

    SBIRPhase I2011Department of Defense Defense Advanced Research Projects Agency

Agency Micro-sites

US Flag An Official Website of the United States Government